Xvivo Perfusion AB(GB:0RKL)
kr 206.00+3.60 (+1.78%)
GB:0RKL
Xvivo Perfusion AB ownership
kr 206.00
At close:+3.60 (+1.78%)
Xvivo Perfusion AB (0RKL) Ownership - Who Owns Xvivo Perfusion AB?
0 Followers
Xvivo Perfusion AB (0RKL) Ownership Overview
- 3.32% Mutual Funds
- 4.76% ETFs
- 91.92% Public Companies and Individual Investors
The ownership structure of Xvivo Perfusion AB (GB:0RKL) stock is a mix of institutional, retail, and individual investors. Approximately 8.08% of the company’s stock is owned by Institutional Investors, and 91.92% is owned by Public Companies and Individual Investors.
The ownership structure of Xvivo Perfusion AB (GB:0RKL) stock is a mix of institutional, retail, and individual investors. Approximately 8.08% of the company’s stock is owned by Institutional Investors, and 91.92% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard | 795,309 | Institution | 2.52% | 16,260,888 |
| Ishares | 425,907 | Institution | 1.35% | 8,708,095 |
| Vanguard Star Funds | 351,131 | Institution | 1.11% | 7,179,224 |
| Vanguard Tax-managed Funds | 237,958 | Institution | 0.76% | 4,865,289 |
| Vanguard International Equity Index Funds | 168,094 | Institution | 0.53% | 3,436,850 |
| Manager Directed Portfolios | 121,700 | Institution | 0.39% | 2,488,278 |
| Usaa Mutual Funds Trust | 109,195 | Institution | 0.35% | 2,232,601 |
| Bnp Paribas | 69,724 | Institution | 0.22% | 1,425,577 |
| Xtrackers | 60,768 | Institution | 0.19% | 1,242,463 |
| Schwab | 51,054 | Institution | 0.16% | 1,043,850 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Star Funds | 351,131 | Institution | 1.11% | 7,179,224 |
| Vanguard Tax-managed Funds | 237,958 | Institution | 0.76% | 4,865,289 |
| Vanguard International Equity Index Funds | 168,094 | Institution | 0.53% | 3,436,850 |
| Manager Directed Portfolios | 121,700 | Institution | 0.39% | 2,488,278 |
| Usaa Mutual Funds Trust | 109,195 | Institution | 0.35% | 2,232,601 |
| Federated Hermes Adviser Series | 18,637 | Institution | 0.06% | 381,052 |
| Fidelity Salem Street Trust | 15,905 | Institution | 0.05% | 325,194 |
| Fidelity Concord Street Trust | 7,398 | Institution | 0.02% | 151,260 |
| Russell Investment Co | 6,843 | Institution | 0.02% | 139,912 |
| State Street Institutional Investment Trust | 5,791 | Institution | 0.02% | 118,403 |
FAQ
What percentage of Xvivo Perfusion AB (GB:0RKL) stock is held by institutional investors?
According to the latest TipRanks data, approximately 8.08% of Xvivo Perfusion AB (GB:0RKL) stock is held by institutional investors: 3.32% by mutual funds and 4.76% by ETFs.
What percentage of Xvivo Perfusion AB (GB:0RKL) stock is held by retail investors?
According to the latest TipRanks data, approximately 91.92% of Xvivo Perfusion AB (GB:0RKL) stock is held by public companies and individual investors.
Who owns the most shares of Xvivo Perfusion AB (GB:0RKL)?
Vanguard owns the most shares of Xvivo Perfusion AB (GB:0RKL).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
